Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> CANTOR FITZGERALD Latest News

APR 09, 2013 - Benzinga

A Must Read - Share

UPDATE: Cantor Fitzgerald Raises PT on Synergy Pharmaceuticals on Linzess Discontinuation Expectations

In a report published Tuesday, Cantor Fitzgerald analyst Irina Rivkind reiterated a Buy rating on Synergy Pharmaceuticals (NASDAQ: SGYP), and raised the price target from $12.00 to $15.00. In the report, Rivkind noted, “After reviewing the plecanatide late-breaker abstract we have raised our revenue estimates.

Tags: UPDATE: Cantor Fitzgerald Raises PT on Synergy Pharmaceuticals on Linzess Discontinuation Expectations,  Cantor Fitzgerald Latest News